Tag: Prescription Drugs
Drug Therapy for AUD May Cut Risk for Alcohol-Related Liver Disease
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis
Tezepelumab Effective for Severe, Uncontrolled Asthma
Nearly half of patients experience a complete response to treatment across multiple measures
Regulatory, Patent Reform Needed for Inhalers for Asthma, COPD
Manufacturers have employed various strategies to obtain regulatory exclusivities and patents on inhalers, limiting generic competition
Clinical Predictors Could Guide Lithium Dosage in Bipolar Disorder
Model based on six clinical predictors explained 61.4 and 49.8 percent of variance in body clearance of lithium, respectively, in two cohorts
Albuterol Plus Budesonide Cuts Exacerbations in Asthma
Risk for severe exacerbations significantly lower with as-needed fixed higher-dose combination treatment versus albuterol alone
During Pandemic, Growth of Clinicians With X-Waivers for Buprenorphine Prescribing Slowed
Survey of 126 clinicians helps pinpoint barriers to obtaining waivers, prescribing buprenorphine
Lenacapavir Reduces Viral Load in Multidrug-Resistant HIV-1 Infection
Reduction in viral load from baseline greater with lenacapavir versus placebo among those with multidrug-resistant HIV-1 infection
TXA Seems Safe for Surgery in High-Risk Patients With IT Hip Fracture
No increased risk for mortality or thromboembolic complications seen with use of tranexamic acid among high-risk patients, entire cohort
Buprenorphine Underused for OUD, Particularly Polysubstance Use
Yet, study shows buprenorphine is effective in protecting against overdose in this population
Rare Cases of COVID-19 Relapse Seen With Pfizer Pill
Reports of symptoms returning in patients several days after completing the five-day regimen of Paxlovid
